ANDREW GEALL, Replicate Bioscience

Dr. Andrew Geall is a biotechnology innovator and executive recognized internationally for his pioneering work in mRNA vaccines and nucleic acid delivery. He is currently the Chief Development Officer at Replicate Bioscience, a San Diego-based biotechnology company developing self-replicating RNA (srRNA) medicines for infectious disease, oncology, and autoimmune disorders. He also serves as Chair of the Borad of the Alliance for mRNA Medicines, a global industry organization devoted to advancing the science, development, regulation and adoption of messenger RNA (mRNA) and “next generation encoding RNA” therapeutics and vaccines. His 25-year career reflects a sustained commitment to translating nucleic-acid science into impactful human therapies and advancing the next generation of RNA medicines.